by The global external defibrillators market size was valued at USD 3.9 billion in 2020, and is predicted to be worth around USD 7.5 billion by 2030, registering a CAGR of 10.3% during the forecast period 2022 to 2030.
Download Exclusive Sample of Report@ https://www.visionresearchreports.com/report/sample/39090
Growth Factor
Increasing technological advancements, government initiatives for installation of AEDs at public places, incidence of sudden cardiac arrest, and initiatives by key market players are some of the key drivers of this market. In November 2020, OHS Canada reported that the Defibrillator Registration and Public Access Act (Bill 141) was accepted by the government and is anticipated to increase public access to AEDs in the country. The COVID-19 pandemic significantly boosted the demand for External Defibrillators in spite of the supply chain challenges and other hurdles brought by movement restrictions.
The key factors driving the market growth include rising technological advancements, initiatives for promoting public access AEDs, and the incidence of sudden cardiac arrest. The COVID-19 pandemic increased awareness about defibrillation training and the use of external defibrillators in case of an adverse cardiac event, thus increasing demand for defibrillators. The pandemic also resulted in logistical bottlenecks and operational challenges.
Report Coverage
| Report Scope | Details |
| Market Size | US$ 7.5 billion by 2030 |
| Growth Rate | CAGR of 10.3% From 2022 to 2030 |
| Largest Market | North America |
| Base Year | 2021 |
| Forecast Period | 2022 to 2030 |
| Segments Covered | Product, End-use |
| Regional Scope | North America, Europe, Asia Pacific, Latin America, Middle East & Africa |
| Companies Mentioned | Koninklijke Philips N.V.; Stryker; ZOLL Medical Corporation; Nihon Kohden Corporation; ProgettiSrl; Schiller AG; MS Westfalia GmbH; AMI Italia; Bexen Cardio; Silverline Meditech Pvt. Ltd.; Mediana Co., Ltd.; Shenzhen Mindray Bio-Medical Electronics; CU Medical; BPL Medical Technologies; Corpuls |
By Product Analysis
The manual external defibrillators segment dominated the market and accounted for the largest revenue share of more than 39.0% in 2021. The AEDs segment on the other hand is estimated to witness the fastest CAGR of 9.4% over the forecast period. This is because of growing initiatives by major companies, increasing adoption of defibrillators at healthcare facilities, and deployment of several public access defibrillation programs.
By End-use Analysis
By end use, the hospitals segment held the largest revenue share of over 25.0% in 2021. This is attributable to higher volume of patients received in hospitals, growing adoption of external defibrillators by hospitals, and strategies implemented by key manufacturers.
Rising incidence of hypertension, diabetes, and strokes leading to SCA due to lack of physical activity, unhealthy dietary habits, and smoking is likely to drive demand for defibrillators in hospitals. Zoll, a part of Asahi Kasei, reported that it held the largest share of the defibrillators market used for hospitals and EMS in November 2021.
The public access segment is projected to witness the fastest CAGR of 9.6% over the forecast period owing to supportive initiatives by governments, regulatory agencies, and healthcare institutions to increase the availability of public access AEDs.
By Regional Analysis
North America held a revenue share of more than 43% in 2021. The large share of the North American region can be attributed to the presence of key players, supportive regulations to increase the availability of public access AEDs, and the high adoption of external defibrillators at healthcare facilities.
Europe is estimated to witness the fastest CAGR of 11.2% in the external defibrillators market over the next few years. This is owing to well-established healthcare infrastructure, large geriatric population susceptible to cardiovascular adverse events, and local presence of key companies.
Key Players
- Koninklijke Philips N.V.
- Stryker
- ZOLL Medical Corporation
- Nihon Kohden Corporation
- ProgettiSrl
- Schiller AG
- MS Westfalia GmbH
- AMI Italia
- Bexen Cardio
- Silverline Meditech Pvt. Ltd.
- Mediana Co., Ltd.
- Shenzhen Mindray Bio-Medical Electronics
- CU Medical
- BPL Medical Technologies
- Corpuls
Market Segmentation
- By Product
- Manual External Defibrillators
- Automated External Defibrillators
- Semi-Automated ED
- Fully Automated ED
- Wearable Cardioverter Defibrillators
- By End-use
- Hospital
- Pre Hospital
- Public Access Market
- Alternate Care Market
- Home Healthcare
- Regional
- North America
- U.S.
- Canada
- Europe
- U.K.
- Germany
- France
- Italy
- Spain
- Asia Pacific
- Japan
- China
- India
- Australia
- South Korea
- Latin America
- Brazil
- Mexico
- Argentina
- Colombia
- Middle East & Africa
- South Africa
- Saudi Arabia
- UAE
- North America
Table of Contents
Chapter 1. Introduction
1.1. Research Objective
1.2. Scope of the Study
1.3. Definition
Chapter 2. Research Methodology
2.1. Research Approach
2.2. Data Sources
2.3. Assumptions & Limitations
Chapter 3. Executive Summary
3.1. Market Snapshot
Chapter 4. Market Variables and Scope
4.1. Introduction
4.2. Market Classification and Scope
4.3. Industry Value Chain Analysis
4.3.1. Raw Material Procurement Analysis
4.3.2. Sales and Distribution Channel Analysis
4.3.3. Downstream Buyer Analysis
Chapter 5. Market Dynamics Analysis and Trends
5.1. Market Dynamics
5.1.1. Market Drivers
5.1.2. Market Restraints
5.1.3. Market Opportunities
5.2. Porter’s Five Forces Analysis
5.2.1. Bargaining power of suppliers
5.2.2. Bargaining power of buyers
5.2.3. Threat of substitute
5.2.4. Threat of new entrants
5.2.5. Degree of competition
Chapter 6. Competitive Landscape
6.1.1. Company Market Share/Positioning Analysis
6.1.2. Key Strategies Adopted by Players
6.1.3. Vendor Landscape
6.1.3.1. List of Suppliers
6.1.3.2. List of Buyers
Chapter 7. Global External Defibrillators Market, By Product
7.1. External Defibrillators Market, by Product, 2021-2030
7.1.1. Manual External Defibrillators
7.1.1.1. Market Revenue and Forecast (2017-2030)
7.1.2. Automated External Defibrillators
7.1.2.1. Market Revenue and Forecast (2017-2030)
7.1.3. Wearable Cardioverter Defibrillators
7.1.3.1. Market Revenue and Forecast (2017-2030)
Chapter 8. Global External Defibrillators Market, By End-use
8.1. External Defibrillators Market, by End-use, 2021-2030
8.1.1. Hospital
8.1.1.1. Market Revenue and Forecast (2017-2030)
8.1.2. Pre Hospital
8.1.2.1. Market Revenue and Forecast (2017-2030)
8.1.3. Public Access Market
8.1.3.1. Market Revenue and Forecast (2017-2030)
8.1.4. Alternate Care Market
8.1.4.1. Market Revenue and Forecast (2017-2030)
8.1.5. Home Healthcare
8.1.5.1. Market Revenue and Forecast (2017-2030)
Chapter 9. Global External Defibrillators Market, Regional Estimates and Trend Forecast
9.1. North America
9.1.1. Market Revenue and Forecast, by Product (2017-2030)
9.1.2. Market Revenue and Forecast, by End-use (2017-2030)
9.1.3. U.S.
9.1.3.1. Market Revenue and Forecast, by Product (2017-2030)
9.1.3.2. Market Revenue and Forecast, by End-use (2017-2030)
9.1.4. Rest of North America
9.1.4.1. Market Revenue and Forecast, by Product (2017-2030)
9.1.4.2. Market Revenue and Forecast, by End-use (2017-2030)
9.2. Europe
9.2.1. Market Revenue and Forecast, by Product (2017-2030)
9.2.2. Market Revenue and Forecast, by End-use (2017-2030)
9.2.3. UK
9.2.3.1. Market Revenue and Forecast, by Product (2017-2030)
9.2.3.2. Market Revenue and Forecast, by End-use (2017-2030)
9.2.4. Germany
9.2.4.1. Market Revenue and Forecast, by Product (2017-2030)
9.2.4.2. Market Revenue and Forecast, by End-use (2017-2030)
9.2.5. France
9.2.5.1. Market Revenue and Forecast, by Product (2017-2030)
9.2.5.2. Market Revenue and Forecast, by End-use (2017-2030)
9.2.6. Rest of Europe
9.2.6.1. Market Revenue and Forecast, by Product (2017-2030)
9.2.6.2. Market Revenue and Forecast, by End-use (2017-2030)
9.3. APAC
9.3.1. Market Revenue and Forecast, by Product (2017-2030)
9.3.2. Market Revenue and Forecast, by End-use (2017-2030)
9.3.3. India
9.3.3.1. Market Revenue and Forecast, by Product (2017-2030)
9.3.3.2. Market Revenue and Forecast, by End-use (2017-2030)
9.3.4. China
9.3.4.1. Market Revenue and Forecast, by Product (2017-2030)
9.3.4.2. Market Revenue and Forecast, by End-use (2017-2030)
9.3.5. Japan
9.3.5.1. Market Revenue and Forecast, by Product (2017-2030)
9.3.5.2. Market Revenue and Forecast, by End-use (2017-2030)
9.3.6. Rest of APAC
9.3.6.1. Market Revenue and Forecast, by Product (2017-2030)
9.3.6.2. Market Revenue and Forecast, by End-use (2017-2030)
9.4. MEA
9.4.1. Market Revenue and Forecast, by Product (2017-2030)
9.4.2. Market Revenue and Forecast, by End-use (2017-2030)
9.4.3. GCC
9.4.3.1. Market Revenue and Forecast, by Product (2017-2030)
9.4.3.2. Market Revenue and Forecast, by End-use (2017-2030)
9.4.4. North Africa
9.4.4.1. Market Revenue and Forecast, by Product (2017-2030)
9.4.4.2. Market Revenue and Forecast, by End-use (2017-2030)
9.4.5. South Africa
9.4.5.1. Market Revenue and Forecast, by Product (2017-2030)
9.4.5.2. Market Revenue and Forecast, by End-use (2017-2030)
9.4.6. Rest of MEA
9.4.6.1. Market Revenue and Forecast, by Product (2017-2030)
9.4.6.2. Market Revenue and Forecast, by End-use (2017-2030)
9.5. Latin America
9.5.1. Market Revenue and Forecast, by Product (2017-2030)
9.5.2. Market Revenue and Forecast, by End-use (2017-2030)
9.5.3. Brazil
9.5.3.1. Market Revenue and Forecast, by Product (2017-2030)
9.5.3.2. Market Revenue and Forecast, by End-use (2017-2030)
9.5.4. Rest of LATAM
9.5.4.1. Market Revenue and Forecast, by Product (2017-2030)
9.5.4.2. Market Revenue and Forecast, by End-use (2017-2030)
Chapter 10. Company Profiles
10.1. Koninklijke Philips N.V.
10.1.1. Company Overview
10.1.2. Product Offerings
10.1.3. Financial Performance
10.1.4. Recent Initiatives
10.2. Stryker
10.2.1. Company Overview
10.2.2. Product Offerings
10.2.3. Financial Performance
10.2.4. Recent Initiatives
10.3. ZOLL Medical Corporation
10.3.1. Company Overview
10.3.2. Product Offerings
10.3.3. Financial Performance
10.3.4. Recent Initiatives
10.4. Nihon Kohden Corporation
10.4.1. Company Overview
10.4.2. Product Offerings
10.4.3. Financial Performance
10.4.4. Recent Initiatives
10.5. ProgettiSrl
10.5.1. Company Overview
10.5.2. Product Offerings
10.5.3. Financial Performance
10.5.4. Recent Initiatives
10.6. Schiller AG
10.6.1. Company Overview
10.6.2. Product Offerings
10.6.3. Financial Performance
10.6.4. Recent Initiatives
10.7. MS Westfalia GmbH
10.7.1. Company Overview
10.7.2. Product Offerings
10.7.3. Financial Performance
10.7.4. Recent Initiatives
10.8. AMI Italia
10.8.1. Company Overview
10.8.2. Product Offerings
10.8.3. Financial Performance
10.8.4. Recent Initiatives
10.9. Bexen Cardio
10.9.1. Company Overview
10.9.2. Product Offerings
10.9.3. Financial Performance
10.9.4. Recent Initiatives
10.10. Silverline Meditech Pvt. Ltd.
10.10.1. Company Overview
10.10.2. Product Offerings
10.10.3. Financial Performance
10.10.4. Recent Initiatives
Chapter 11. Research Methodology
11.1. Primary Research
11.2. Secondary Research
11.3. Assumptions
Chapter 12. Appendix
12.1. About Us
12.2. Glossary of Terms
Buy this Research Report study@ https://www.visionresearchreports.com/report/cart/39090
Contact Us:
Vision Research Reports
Call: +1 9197 992 333
